Known as the “great masquerader,” amelanotic melanoma may resemble a variety of benign lesions, thereby increasing diagnostic complexity.
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results